DE60324387D1 - Verwendung von amylin, amylinanaloga und amylin derivaten zur behandlung von dyslipidämie und hypertriglyceridämie - Google Patents

Verwendung von amylin, amylinanaloga und amylin derivaten zur behandlung von dyslipidämie und hypertriglyceridämie

Info

Publication number
DE60324387D1
DE60324387D1 DE60324387T DE60324387T DE60324387D1 DE 60324387 D1 DE60324387 D1 DE 60324387D1 DE 60324387 T DE60324387 T DE 60324387T DE 60324387 T DE60324387 T DE 60324387T DE 60324387 D1 DE60324387 D1 DE 60324387D1
Authority
DE
Germany
Prior art keywords
amylin
amylinanaloga
hypertriglyceridemia
dyslipidemia
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60324387T
Other languages
English (en)
Inventor
Orville G Kolterman
Christian Weyer
David G Maggs
Mark Fineman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
Original Assignee
Amylin Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23362445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60324387(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Amylin Pharmaceuticals LLC filed Critical Amylin Pharmaceuticals LLC
Application granted granted Critical
Publication of DE60324387D1 publication Critical patent/DE60324387D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE60324387T 2002-01-08 2003-01-08 Verwendung von amylin, amylinanaloga und amylin derivaten zur behandlung von dyslipidämie und hypertriglyceridämie Expired - Lifetime DE60324387D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34712802P 2002-01-08 2002-01-08
PCT/US2003/000369 WO2003057244A2 (en) 2002-01-08 2003-01-08 Use of amylin agonists to modulate triglycerides

Publications (1)

Publication Number Publication Date
DE60324387D1 true DE60324387D1 (de) 2008-12-11

Family

ID=23362445

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60324387T Expired - Lifetime DE60324387D1 (de) 2002-01-08 2003-01-08 Verwendung von amylin, amylinanaloga und amylin derivaten zur behandlung von dyslipidämie und hypertriglyceridämie

Country Status (9)

Country Link
US (1) US20030130177A1 (de)
EP (1) EP1474164B1 (de)
AT (1) ATE412421T1 (de)
AU (1) AU2003235742B2 (de)
CA (1) CA2475173A1 (de)
DE (1) DE60324387D1 (de)
ES (1) ES2316757T3 (de)
NZ (1) NZ534557A (de)
WO (1) WO2003057244A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2475173A1 (en) * 2002-01-08 2003-07-17 Amylin Pharmaceuticals, Inc. Use of amylin agonists to modulate triglycerides
DE602006008456D1 (de) 2005-03-31 2009-09-24 Amylin Pharmaceuticals Inc Amylin und amylinagonisten für die behandlung von psychiatrischen erkrankungen und störungen
WO2007014051A2 (en) * 2005-07-22 2007-02-01 Amylin Pharmaceuticals, Inc. Use of amylin and amylin agonists as cardioprotective or myoprotective agents
WO2007104789A2 (en) * 2006-03-15 2007-09-20 Novo Nordisk A/S Amylin derivatives
EP2036923A1 (de) * 2007-09-11 2009-03-18 Novo Nordisk A/S Verbesserte Derivate von Amylin
EP2340261B1 (de) * 2008-10-21 2017-12-20 Novo Nordisk A/S Amylinderivate
WO2011058193A1 (en) 2009-11-16 2011-05-19 Mellitech [1,5]-diazocin derivatives
BR102013017626A2 (pt) * 2013-06-14 2015-02-10 Univ Rio De Janeiro Bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, uso de bioconjugados não aglomerantes de amilinomiméticos com polietilenoglicol, composições farmacêuticas de baixa toxicidade, adjuvante para a prevenção ou tratamento das doenças, medicamento, método de tratamento ou prevenção de doenças.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
US5367052A (en) * 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
CA2115159A1 (en) * 1991-08-08 1993-02-09 Jeffrey A. Bibbs Production of peptide amides
US6143718A (en) * 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
DE69831673C5 (de) * 1997-01-07 2015-01-22 Amylin Pharmaceuticals, Llc Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme
AU6585498A (en) * 1997-04-04 1998-10-30 Amylin Pharmaceuticals, Inc. Novel uncoupling protein and methods of use
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US6087334A (en) * 1998-08-21 2000-07-11 Amylin Pharmaceuticals, Inc. Anti-diabetic peptides
CN1186017C (zh) * 2001-10-09 2005-01-26 陈立民 防治糖尿病、高脂血症和肥胖症的药物的配制方法
CA2475173A1 (en) * 2002-01-08 2003-07-17 Amylin Pharmaceuticals, Inc. Use of amylin agonists to modulate triglycerides

Also Published As

Publication number Publication date
US20030130177A1 (en) 2003-07-10
NZ534557A (en) 2007-10-26
EP1474164A2 (de) 2004-11-10
CA2475173A1 (en) 2003-07-17
ATE412421T1 (de) 2008-11-15
WO2003057244A3 (en) 2003-12-18
AU2003235742A1 (en) 2003-07-24
EP1474164B1 (de) 2008-10-29
ES2316757T3 (es) 2009-04-16
WO2003057244A2 (en) 2003-07-17
AU2003235742B2 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
CY1115361T1 (el) Στερεες μορφες περιλαμβανοντας (+)-2-[1-(3-αιθοξυ-4-μεθοξυφαινυλ)-2-μεθυλσουλφονυλαιθυλ]-4-ακετυλαμινοϊσοϊνδολιν-1,3-διονη, συνθεσεις εξ' αυτων, και χρησεις εξ' αυτων
DE69737592D1 (de) Mittel gegen juckreiz
ATE414089T1 (de) Verwendung von rapamycin und dessen derivaten zur behandlung von knochenverlust
YU21401A (sh) Tetrahidropiridoetri
ATE553086T1 (de) Substituierte heterocyclische verbindungen und deren verwendung zur behandlung der multipler medikamentenresistenz
NO20052760D0 (no) Fremgangsmate for behandling av kreft og beslektede fremgangsmater.
DE60033030D1 (de) Verwendung von gegen cd20 gerichteten antikörpern zur behandlung der graft versus host krankheit
ATE447559T1 (de) 4-(phenylamino)-6-oxo-1,6-dihydropyridazine-3- carboxamid derivate als mek inhibitoren zur behandlung von hyperproliferativen erkrankungen
ATE279181T1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
DE60137307D1 (de) Substituierte sapogenine und ihre verwendung
BR0202519B1 (pt) métodos para tratamento de material de madeira e para tratamento microbicida de material de madeira.
ATE336996T1 (de) Verwendung von flavonoid-derivaten zur behandlung von atopischem ekzem
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60008143D1 (de) Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
ATE480265T1 (de) Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen
WO2003075953A3 (en) Immunomodulatory polymeric antigens for treating inflammatory pathogies
DE60324387D1 (de) Verwendung von amylin, amylinanaloga und amylin derivaten zur behandlung von dyslipidämie und hypertriglyceridämie
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE602005010258D1 (de) Behandlung von ballastwasser
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
NO20060420L (no) 2-aminobenzoylderivater
DE69827387D1 (de) Verwendung von pramipexol zur behandlung von restless-legs-syndrom
DE60213365D1 (de) Verwendung von mglur5 antagonisten zur behandlung von pruritischen zuständen
MXPA02004700A (es) Compuestos relacionados con acido 15-hidroxieicosatetraenoico y metodos de uso.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: HOFFMANN & EITLE, 81925 MUENCHEN